Aberrant promoter DNA methylation inhibits bone morphogenetic protein 2 expression and contributes to drug resistance in breast cancer

JOURNAL ARTICLE published August 2014 in Molecular Medicine Reports

Authors: MIN DU | XIAO-MEI SU | TAO ZHANG | YONG-JUN XING